Dana Ďuricová

5.0k total citations
92 papers, 2.2k citations indexed

About

Dana Ďuricová is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Dana Ďuricová has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 40 papers in Epidemiology and 38 papers in Immunology. Recurrent topics in Dana Ďuricová's work include Inflammatory Bowel Disease (57 papers), Microscopic Colitis (33 papers) and Eosinophilic Esophagitis (19 papers). Dana Ďuricová is often cited by papers focused on Inflammatory Bowel Disease (57 papers), Microscopic Colitis (33 papers) and Eosinophilic Esophagitis (19 papers). Dana Ďuricová collaborates with scholars based in Czechia, Denmark and Italy. Dana Ďuricová's co-authors include Milan Lukáš, Martin Bortlík, Tine Jess, Karin Malíčková, Pia Munkholm, Naděžda Machková, Margarita Elkjær, Corinne Gower‐Rousseau, Michael Gamborg and Natalia Pedersen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Dana Ďuricová

79 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Ďuricová Czechia 25 1.3k 953 784 718 502 92 2.2k
Mark T. Osterman United States 31 2.1k 1.6× 1.7k 1.7× 781 1.0× 707 1.0× 517 1.0× 157 3.2k
Fraser Cummings United Kingdom 26 1.0k 0.8× 742 0.8× 533 0.7× 791 1.1× 174 0.3× 108 2.3k
Waqqas Afif Canada 27 2.0k 1.5× 1.7k 1.8× 775 1.0× 676 0.9× 254 0.5× 143 2.8k
Casper Steenholdt Denmark 26 1.6k 1.2× 1.1k 1.2× 317 0.4× 1.1k 1.5× 258 0.5× 85 2.4k
Fernando Bermejo Spain 30 1.3k 1.0× 1.0k 1.1× 1.3k 1.6× 387 0.5× 374 0.7× 137 2.8k
Vivian Huang Canada 26 1.1k 0.8× 595 0.6× 709 0.9× 849 1.2× 806 1.6× 98 2.2k
Mathurin Fuméry France 29 2.2k 1.7× 1.7k 1.8× 1.0k 1.3× 788 1.1× 304 0.6× 198 3.3k
Zuzana Zelinková Netherlands 23 822 0.6× 497 0.5× 648 0.8× 1.0k 1.5× 922 1.8× 56 2.2k
John Fell United Kingdom 18 1.5k 1.1× 1.1k 1.1× 818 1.0× 374 0.5× 181 0.4× 29 2.0k
Mary Sherlock Canada 11 1.4k 1.0× 955 1.0× 761 1.0× 345 0.5× 190 0.4× 35 1.8k

Countries citing papers authored by Dana Ďuricová

Since Specialization
Citations

This map shows the geographic impact of Dana Ďuricová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Ďuricová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Ďuricová more than expected).

Fields of papers citing papers by Dana Ďuricová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Ďuricová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Ďuricová. The network helps show where Dana Ďuricová may publish in the future.

Co-authorship network of co-authors of Dana Ďuricová

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Ďuricová. A scholar is included among the top collaborators of Dana Ďuricová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Ďuricová. Dana Ďuricová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahadevan, Uma, Cynthia H. Seow, Edward L. Barnes, et al.. (2025). Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 121(1). 31–79. 2 indexed citations
2.
Ďuricová, Dana, et al.. (2024). News in gastroenterology, hepatology and digestive endoscopy. Vnitřní lékařství. 70(5). 318–325.
3.
4.
Ďuricová, Dana, Martin Kolář, Naděžda Machková, et al.. (2023). Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?. Crohn s & Colitis 360. 5(4). otad040–otad040. 10 indexed citations
5.
Lukáš, Milan, Veronika Hrubá, Naděžda Machková, et al.. (2023). Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study. 77(4). 336–341. 1 indexed citations
6.
Ďuricová, Dana, Martin Lukáš, Naděžda Machková, et al.. (2022). Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients. Journal of Crohn s and Colitis. 16(9). 1347–1353. 8 indexed citations
7.
Malíčková, Karin, Martin Bortlík, Dana Ďuricová, et al.. (2020). Telemedicine and inflammatory bowel disease – results of the IBD Assistant pilot project. 74(1). 18–27. 1 indexed citations
8.
Ďuricová, Dana, Eva Dvořáková, Ondřej Hradský, et al.. (2018). Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation. Inflammatory Bowel Diseases. 25(4). 789–796. 61 indexed citations
9.
Ďuricová, Dana, Benjamin Pariente, Hélène Sarter, et al.. (2018). Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study. Digestive and Liver Disease. 50(9). 903–909. 11 indexed citations
10.
Ďuricová, Dana, Mathurin Fumery, Vito Annese, et al.. (2016). The natural history of Crohn’s disease in children: a review of population-based studies. European Journal of Gastroenterology & Hepatology. 29(2). 125–134. 52 indexed citations
11.
Végh, Zsuzsanna, Johan Burisch, Ioannis Kaimakliotis, et al.. (2016). P668. Medical therapy, surgery and hospitalisation rates during the 2- and 3-year follow-up of the 2011 ECCO-EpiCom cohort. Journal of Crohn s and Colitis. 10(suppl 1). S442–S443. 1 indexed citations
12.
Ferrante, Marc, Dana Ďuricová, Geert D’Haens, et al.. (2014). P338 Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn's disease recurrence. Journal of Crohn s and Colitis. 8. S205–S206. 2 indexed citations
13.
Ďuricová, Dana, Johan Burisch, Tine Jess, Corinne Gower‐Rousseau, & Péter L. Lakatos. (2014). Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. Journal of Crohn s and Colitis. 8(11). 1351–1361. 124 indexed citations
14.
Ďuricová, Dana. (2013). Mesalazin u Crohnovy nemoci: obsolentní nebo neprávem opomíjená léčba?. 67(1).
15.
Hrdlička, Luděk, Kseniya Dryahina, Patrik Španěl, et al.. (2012). Tu1248 Noninvasive Quantification of Volatile Metabolites in Breath: A Potential Indicator of Inflammatory Bowel Diseases Activity. Gastroenterology. 142(5). S–784. 2 indexed citations
16.
Ďuricová, Dana, Natalia Pedersen, Johan Burisch, et al.. (2011). Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab. Gastroenterology. 140(5). S–203. 3 indexed citations
17.
Malíčková, Karin, Marta Kalousová, Martin Bortlík, et al.. (2010). Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes. Scandinavian Journal of Clinical and Laboratory Investigation. 70(4). 294–299. 12 indexed citations
18.
Ďuricová, Dana, et al.. (2010). Terapie inhibitory protonové pumpy v ambulanci internistů a kardiologů. Interní medicína pro praxi. 12(10). 466–469. 1 indexed citations
19.
Pedersen, Natalia, Dana Ďuricová, Margarita Elkjær, et al.. (2010). Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies. The American Journal of Gastroenterology. 105(7). 1480–1487. 205 indexed citations
20.
Lukáš, Milan, Karin Malíčková, Martin Bortlík, & Dana Ďuricová. (2009). W1212 Anti-Infliximab Antibodies in Routine Clinical Practice - Is It Worth to Assess Them?. Gastroenterology. 136(5). A–679.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark T. Osterman Breakdown of academic impact, for papers by Fraser Cummings Breakdown of academic impact, for papers by Waqqas Afif Breakdown of academic impact, for papers by Casper Steenholdt Breakdown of academic impact, for papers by Fernando Bermejo Breakdown of academic impact, for papers by Vivian Huang Breakdown of academic impact, for papers by Mathurin Fuméry Breakdown of academic impact, for papers by Zuzana Zelinková Breakdown of academic impact, for papers by John Fell Breakdown of academic impact, for papers by Mary Sherlock
Rankless by CCL
2026